The government of the United Kingdom launches a proposal for an International Finance Facility (IFF) to provide significant additional funds for immediate development assistance. The proposal was inspired by the commitment of all members of the United Nations to meet the Millennium Development Goals by 2015.
UK and France make the IFF a reality
The United Kingdom and France announce their commitment to launch an International Finance Facility for Immunisation (IFFIm) - a pilot that would apply the principles of the broader IFF on a smaller scale to the immunisation sector.
Key European nations join the UK and France
The United Kingdom, France, Italy, Spain and Sweden commit nearly US$ 4 billion to support and scale up the work of Gavi through the launch of IFFIm. This innovative "frontloading" approach is estimated to prevent the deaths of more than five million children from vaccine-preventable diseases.
Norway joins IFFIm
At the 3rd Gavi Partners Meeting in New Delhi, Prime Minister Jens Stoltenberg announces the Government of Norway to join IFFIm by pledging US$ 27 million over five years, becoming its sixth government donor.
IFFIm issues inaugural Vaccine Bonds
IFFIm raises US$ 1 billion through the inaugural issue of bonds to institutional investors, accelerating the availability of funds to be used for health and immunisation programmes through Gavi. The new funds will enable Gavi to build on its success and immunise more than 500 million children against vaccine-preventable diseases before 2015.
South Africa joins IFFIm
The Republic of South Africa joins IFFIm, becoming its seventh government donor. With a commitment of US$ 20 million, South Africa becomes the first emerging market country donor to contribute to IFFIm.
IFFIm raises almost US$ 1 billion in first year
IFFIm approaches US$ 1 billion raised in its first year, providing US$ 995 million to 43 of the world's poorest countries to spend on life-saving immunisation and health programmes.
Japanese investors welcome Vaccine Bonds
The second IFFIm bond sale secures US$ 223 million from private investors in Japan. IFFIm's debut in Japan is the largest South African rand-denominated bond to date in the Uridashi market.
The Netherlands joins IFFIm
The Netherlands displays its strong desire to stimulate innovation and to involve the private sector in development by pledging €60 million over eight years to IFFIm, becoming its eighth government donor.
IFFIm prices inaugural benchmark in Australian dollars
The AUD 400 million, five-year bonds demonstrate institutional investors’ continued support for IFFIm and its humanitarian purpose.
Australia joins IFFIm
Australia joins IFFIm by pledging AU$ 250 million over 20 years, becoming its ninth government donor.
Independent evaluation of IFFIm
An independent evaluation of IFFIm by health care consulting firm HLSP concludes that IFFIm provides “extremely good development returns” and has helped “transform Gavi from a niche actor into a major player in international health.” The report cites IFFIm as a low-cost, efficient model, helping Gavi save an additional 2.1 million lives while delivering more than three times the value of each dollar spent.
IFFIm gets a new board chair
Chair Alan Gillespie steps down after six years, during which time
IFFIm received pledges worth US$ 6.3 billion, helping it raise US$
3.6 billion in bond proceeds. René Karsenti is appointed the new Chair.
IFFIm vaccine bonds rated among 25 most influential
IFFIm’s early 2008 inaugural retail bond issue in Japan (see above) is cited by EuroWeek magazine as among the 25 most influential deals, helping set a trend of ethically-themed bonds sold in Japan.
IFFIm honoured as a socially responsible investment
IFFIm is cited as “SRI Innovation of the Decade” by mtn-i, a news, data and analytics provider.
IFFIm raises US$ 700 million
IFFIm issues its largest financing since its inaugural benchmark, raising US$ 700 million in a transaction jointly led by Daiwa Securities Group and Deutsche Bank. It is IFFIm’s first floating rate offer.
IFFIm issues its first sukuk, raising US$ 500 million
IFFIm entered the sukuk market for the first time, raising US$ 500 million with a 3-year socially responsible investment that complies with Islamic law. The sukuk was coordinated by Standard Charted Bank, working with joint lead managers from four Muslim countries: National Bank of Abu Dhabi, Barwa Bank of Qatar, NCB Capital of Saudi Arabia and CIMB of Malaysia.
Inaugural sukuk awarded multiple prizes
IFFIm’s first sukuk transaction received the Financial Times’ Achievement in International Finance Award, Islamic Finance News’ Social Impact Deal of the Year 2014, EMEA Finance’s Best Supranational Sukuk and Euromoney’s Innovation in Islamic Finance and Global Finance Magazine’s Islamic Deal of the Year.
Australia, France and the Netherlands increase commitments
Three IFFIm donors – Australia, France and the Netherlands – commit an additional US$ 280 million to IFFIm as Gavi’s pledging conference in Berlin, supporting efforts to immunise 300 million children between 2016-2020, preventing an additional 5 million to 6 million deaths. France increase its pledge by €150 million, adding to its €1.24 billion, 20-year pledge. The Netherlands increased its long-term pledge by €60 million and four years, adding to its €80 million, 8-year pledge. Australia increased its pledge by AU$ 37.5 million, adding to its AU$ 250 million, 20-year pledge.
Addis action agenda highlights IFFIm model
At the Third International Conference on Financing for Development, the global development community recognised IFFIm's unique value and encouraged exploring its potential applicability to wider development efforts.
IFFIm issues second sukuk, raising US$ 200 million
IFFIm entered the Islamic finance market for the second time, raising US$ 200 million with a 3-year socially responsible investment that complies with Islamic law the sukuk was coordinated by Standard Charted Bank, working with joint lead managers Emirates NBD Capital Limited (Dubai), Maybank Kim Eng (Maybank), National Bank of Abu Dhabi (NBAD) and NCB Capital Company (NCB Capital).